Onconetix, Inc. (ONCO) vs Reviva Pharmaceuticals Holdings, Inc. (RVPH)
Onconetix, Inc. and Reviva Pharmaceuticals Holdings, Inc. are both Biotechnology companies. Onconetix, Inc. and Reviva Pharmaceuticals Holdings, Inc. are of similar size ($5.0M and $4.6M). Reviva Pharmaceuticals Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Onconetix, Inc. trades at 0.0×. Reviva Pharmaceuticals Holdings, Inc. has the higher net margin (0.00% vs −1,578.6%) and the higher return on invested capital (0.00% vs −135.4%). Across the 13 metrics below, Onconetix, Inc. leads on 7 and Reviva Pharmaceuticals Holdings, Inc. on 6.
Valuation
Profitability
| Metric | ONCO | RVPH | Biotechnology median |
|---|---|---|---|
| Gross margin | 80.38% | — | 65.16% |
| Operating margin | (2,524.73%) | 0.00% | 0.00% |
| Net margin | (1,578.60%) | 0.00% | 0.00% |
| Free cash flow margin | (1,595.90%) | 0.00% | 0.00% |
| Return on equity | (105.23%) | (176.60%) | (57.72%) |
| Return on assets | (57.37%) | (79.46%) | (49.22%) |
| Return on invested capital | (135.42%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack